Author`s name Pravda.Ru

Usage of GlaxoSmithKline's Tykerb leads to tumor regression - Comments

GlaxoSmithKline Plc. claimed that its drug Tykerb reduces the number of stem cells that can cause breast cancer to recur.

Show more

Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.